| __timestamp | Amphastar Pharmaceuticals, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 51256000 | 27632226 |
| Thursday, January 1, 2015 | 77347000 | 97707000 |
| Friday, January 1, 2016 | 104189000 | 129037000 |
| Sunday, January 1, 2017 | 90795000 | 151332000 |
| Monday, January 1, 2018 | 106985000 | 158719000 |
| Tuesday, January 1, 2019 | 131923000 | 170104000 |
| Wednesday, January 1, 2020 | 143340000 | 192195000 |
| Friday, January 1, 2021 | 199739000 | 220706000 |
| Saturday, January 1, 2022 | 248860000 | 204426000 |
| Sunday, January 1, 2023 | 351121000 | 133788000 |
Infusing magic into the data realm
In the dynamic world of pharmaceuticals, understanding financial trends is crucial. From 2014 to 2023, Amphastar Pharmaceuticals, Inc. and Travere Therapeutics, Inc. have shown intriguing gross profit trajectories. Amphastar's gross profit surged by approximately 585%, peaking in 2023, while Travere's growth was more modest, with a 384% increase, reaching its zenith in 2021. Notably, Amphastar's profits soared in 2023, marking a significant leap from previous years. In contrast, Travere experienced a decline in 2023, highlighting the volatile nature of the industry. These trends underscore the importance of strategic financial planning and market adaptability. As the pharmaceutical landscape evolves, companies must navigate challenges and opportunities to sustain growth. This analysis offers a glimpse into the financial health and strategic positioning of these two industry players over the past decade.
Gross Profit Trends Compared: Novo Nordisk A/S vs Travere Therapeutics, Inc.
Key Insights on Gross Profit: Sanofi vs Travere Therapeutics, Inc.
Zoetis Inc. vs Travere Therapeutics, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Bio-Techne Corporation and Travere Therapeutics, Inc. Trends
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc. Trends
Gross Profit Trends Compared: Vericel Corporation vs Amphastar Pharmaceuticals, Inc.
HUTCHMED (China) Limited and Travere Therapeutics, Inc.: A Detailed Gross Profit Analysis
Amphastar Pharmaceuticals, Inc. or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?
Gross Profit Analysis: Comparing Amphastar Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd.
Gross Profit Analysis: Comparing Amphastar Pharmaceuticals, Inc. and Evotec SE
SG&A Efficiency Analysis: Comparing Amphastar Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Travere Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown